51
Participants
Start Date
April 21, 2023
Primary Completion Date
January 26, 2028
Study Completion Date
May 16, 2028
BNT116
BNT116 is administered by IV injection.
Cemiplimab
Cemiplimab is administered Q3W by IV infusion
Tri-Service General Hospital, Taipei
Seoul National University Hospital, Seoul
Kaohsiung Medical University - Chung-Ho Memorial Hospital, Kaohsiung City
Yonsei Severance, Seoul
LTD High Technology Hospital Medcenter, Batumi
Samsung Medical Center, Seoul
Weill Cornell Medicine, New York
National Cancer Center Korea, Goyang
Consorcio Hospitalario Provincial de Castellon, Castellon
Virginia Cancer Specialists, Fairfax
Taipei Tzu Chi Hospital, New Taipei City
Taipei Medical University - Shuang Ho Hospital, New Taipei City
Hospital General Universitario Gregorio Marañon (HGUGM), Madrid
Clinica Universidad de Navarra - Madrid, Madrid
Hospital Universitario Fundacion Jimenez Diaz, Madrid
FirstHealth of the Carolinas Outpatient Cancer Center, Pinehurst
Hospital Regional Universitario de Malaga, Málaga
Hospital Universitario Virgen del Rocio, Málaga
Clinica Universidad de Navarra, Pamplona
Bezmialem Foundation University Medical Faculty, Istanbul
Yeditepe University Kosuyolu Hospital, Kadıköy
Ege University Faculty of Medicine, Bornova
Izmir Economy University Medical Point Hospital, Izmir
Norton Cancer Institute, Downtown, Louisville
Instituto Valenciano de Oncologia, Valencia
Hospital Universitari i Politecnic La Fe de Valencia, Valencia
Chonnam National University Hwasun Hospital, Hwasun
Klinikum der Johann Wolfgang Goethe-Universitaet Frankfurt, Frankfurt
Millenium Research & Clinical Development, Houston
Universitaetsklinikum Giessen Und Marburg Gmbh Standort Giessen, Giessen
Istanbul Medeniyet University - Prof Dr Suleyman Yalcin Sehir Hospital, Istanbul
Staedtisches Klinikum Muenchen Bogenhausen, München
Klinikverbund Kempten-Oberallgäu, Kempten
San Juan Oncology Associates, Farmington
The Oncology Institute of Hope and Innovation, Los Angeles
UCLA Medical Center, Santa Monica
Northwest Medical Specialties, PLLC, Tacoma
National Taiwan University Hospital, Taipei
LLC Todua Clinic, Tbilisi
LTD New Hospitals, Tbilisi
LTD Tbilisi State Medical University and Ingorokva High Medical Technology University Clinic, Tbilisi
LTD Cancer Research Centre, Tbilisi
Caucasus Medical Centre, Tbilisi
Krankenhaus Martha-Maria Halle-Doelau gGmbH, Halle
Korea University Anam Hospital, Seoul
Asan Medical Center, Seoul
Catalan Institute of Oncology Badalona, Badalona
Althaia Xarxa Assistencial Universitaria Manresa, Manresa
Adana Medical Park Seyhan Hospital, Adana
Baskent University, Yüreğir
Ozel Liv Hospital, Ankara
Sbu Doctor Abdurrahman Yurtaslan Ankara Onkoloji Suam, Ankara
Collaborators (1)
BioNTech SE
INDUSTRY
Regeneron Pharmaceuticals
INDUSTRY